Saalman R, Carlsson B, Fällström S P, Hanson L A, Ahlstedt S
Department of Clinical Immunology, University of Göteborg, Sweden.
Clin Exp Immunol. 1991 Sep;85(3):446-52. doi: 10.1111/j.1365-2249.1991.tb05747.x.
The capacity of serum antibodies against beta-lactoglobulin to mediate antibody-dependent cell-mediated cytotoxicity (ADCC) was analysed in sera from children with cow's milk protein intolerance (CMPI). The children with CMPI were divided into three groups according to clinical features: delayed-onset CMPI with gastrointestinal symptoms (n = 8); immediate-onset CMPI with gastrointestinal and skin symptoms (n = 8); and immediate-onset CMPI with skin symptoms only (n = 8). The CMPI groups were compared with children with untreated (n = 9) or treated (n = 8) coeliac disease and a control group (n = 22). Sera from the children were examined for cytotoxic effects using lymphocytes from healthy adults as effector cells and radiolabelled beta-lactoglobulin-coated erythrocytes from the same donor as target cells. In addition, IgG and IgA serum antibodies against beta-lactoglobulin were determined with ELISA. Sera from children with CMPI and gastrointestinal symptomatology showed a significantly increased capacity to induce ADCC reactivity as compared with controls. This increased capacity was seen in sera from those with immediate as well as delayed onset of the gastrointestinal symptoms. In contrast, sera from children who had an immediate-onset CMPI with only skin symptoms mediated no such increase in ADCC reactivity. Moreover, children with coeliac disease with a few exceptions, demonstrated low ADCC reactivity, despite the fact that they had high levels of antibodies against beta-lactoglobulin. ADCC may be an immunopathogenic mechanism in certain cases of CMPI with gastrointestinal symptoms.
分析了牛奶蛋白不耐受(CMPI)患儿血清中抗β-乳球蛋白抗体介导抗体依赖性细胞介导的细胞毒性(ADCC)的能力。根据临床特征,将CMPI患儿分为三组:伴有胃肠道症状的迟发性CMPI(n = 8);伴有胃肠道和皮肤症状的速发性CMPI(n = 8);仅伴有皮肤症状的速发性CMPI(n = 8)。将CMPI组与未经治疗(n = 9)或已治疗(n = 8)的乳糜泻患儿及一个对照组(n = 22)进行比较。使用来自健康成年人的淋巴细胞作为效应细胞,以及来自同一供体的放射性标记的β-乳球蛋白包被的红细胞作为靶细胞,检测患儿血清的细胞毒性作用。此外,用酶联免疫吸附测定法(ELISA)测定血清中抗β-乳球蛋白的IgG和IgA抗体。与对照组相比,患有CMPI和胃肠道症状的患儿血清诱导ADCC反应性的能力显著增加。在胃肠道症状速发和迟发的患儿血清中均观察到这种能力增加。相比之下,仅患有皮肤症状的速发性CMPI患儿血清介导的ADCC反应性没有这种增加。此外,除少数例外,乳糜泻患儿尽管抗β-乳球蛋白抗体水平较高,但ADCC反应性较低。ADCC可能是某些伴有胃肠道症状的CMPI病例中的一种免疫致病机制。